pocketful logo
Ishita Drugs & Industries Ltd logo

Ishita Drugs & Industries Ltd

NSE: BSE: 524400

76.54

(-4.86%)

Sat, 14 Mar 2026, 00:28 am

Ishita Drugs & Industries Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    24.19

  • Net Profit

    0.87

  • P/B

    2.18

  • Sector P/E

    40.97

  • P/E

    27.08

  • EV/EBITDA

    16.83

  • Debt/Equity (Industry)

    0.16

  • Interest Cover (Industry)

    20.20

  • ROCE (Industry)

    20.50

  • RONW (Industry)

    17.60

  • ROE

    8.40

  • ROCE

    10

  • Debt/Equity

    0.19

  • EPS (TTM)

    2.97

  • Dividend Yield

    0

  • Book Value

    37.58

  • Interest Cover

    17.57

Analysis

all

thumbs up icon

Pros

  • Ishita Drugs & Industries is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Ishita Drugs & Industries is profitable, therefore cash runway is not a concern.
  • Ishita Drugs & Industries is profitable, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (485.4%, greater than 20% of total debt).
  • Debt is covered by short term assets, assets are 52.2x debt.
thumbs up icon

Cons

  • Unable to evaluate Ishita Drugs & Industries's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Ishita Drugs & Industries's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • The level of debt compared to net worth has increased over the past 5 years (2.2% vs 2.4% today).
  • High level of physical assets or inventory.
  • Ishita Drugs & Industries is not covered by any analysts.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters50.0449.9649.9249.9149.84
FII00000
DII00000
Public49.9650.0450.0850.0950.16
Government00000

Read More

Technical Analysis

RSI

62.66

MACD

1.27

50 DMA

72.84

200 DMA

75.18

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic88.9780.1275.5571.2766.7062.4253.57
Fibonacci80.1276.7474.6571.2767.8965.8062.42
Camarilla73.4072.5971.7871.2770.1669.3568.54

Pivots Level: Classic

R3

+17.70

88.97

R2

+8.85

80.12

R1

+4.27

75.55

71.27
71.27
Pivot Point
LTP: 80.90

S1

-4.58

66.70

S2

-8.85

62.42

S3

-17.70

53.57

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    74.39

  • 20-EMA

    72.90

  • 30-EMA

    72.55

  • 50-EMA

    72.60

  • 100-EMA

    73.35

  • 200-EMA

    74.71

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
07 Feb 2026board-meetingsQuarterly Results
02 Sept 2025agm
27 Aug 2024agm
28 Aug 2023agm
09 Sept 2022agm
31 Aug 2021agm

Read More

Peer Comparison

Ishita Drugs & Industries Ltd logo

Ishita Drugs & Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Ishita Drugs & Industries Ltd About

Ishita Drugs & Industries is engaged in the business of manufacturing of various APIs (Active Pharma Ingredients) and drug intermediates. It has built up a reputation as a manufacturer of “high quality” products and is known for its ethical dealings in business.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1992

Headquarters

CEO

Employees

Contact

Website icon

Website

http://www.ishitadrugs.com

Email icon

Email

ishitadrugs@vsnl.net

Phone icon

Phone

Location icon

Location

Survey No 179/1 Taluka Sanand, Village Vasna-Iyava, Ahmedabad, Gujarat, 382170

Read More

Ishita Drugs & Industries Ltd Company History

YearHistory
1992
  • Ishita Drugs and Industries Ltd. was incorporated.
  • Ishita Drugs and Industries Ltd. obtained the certificate for commencement of business.
2005
  • Ishita Drugs secured an export order for API and PUMOJEL.
2012
  • Ishita Drugs & Industries Limited was declared Best SME For Corporate Governance at The Business Today-Yes Bank SME Awards 2011.
2013
  • Ishita Drugs & Industries Ltd appointed Mr. Niranjan Agrawal as a non-executive, independent director.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
BHUPESHBHAI VAHLABHAI PATELSell249977715 Sept 2025
ISHITA PHARMACEUTICALSBuy2533476.9915 Sept 2025
USHA JAWAHARLAL KALROBuy2268975.1911 Sept 2025
BHUPESHBHAI VAHLABHAI PATELSell2020075.3411 Sept 2025
USHA JAWAHARLAL KALROSell2268977.5811 Sept 2025
RAJAN MALHOTRABuy1842183.1225 Nov 2024
PUNEET MITTAL HUFSell2571489.1525 Nov 2024
PUNEET MITTAL HUFBuy2571488.2825 Nov 2024
VIKKRAMM CHANDIRRAMANIBuy3993479.8917 Sept 2024
BHUPESHBHAI VAHLABHAI PATELSell350008017 Sept 2024

Read More

Ishita Drugs & Industries Ltd News

Ishita Drugs Related Party Acquires 506 Shares

Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, acquired 506 shares worth Rs. 10 each through open market purchase on February 24, 2026, increasing its stake to 1.08%.

24 Feb 2026

co actions results

Ishita Drugs Discloses Substantial Acquisition Filing

Ishita Drugs and Industries Limited files disclosure under SEBI regulations for substantial acquisition involving Ishita Pharmaceuticals as acquirer, with 30,550 shares mentioned in regulatory filing.

14 Feb 2026

co actions results

Ishita Drugs Q3FY26 Results: Revenue Drops 24%

Ishita Drugs & Industries reported Q3FY26 revenue of ₹313.62 lakhs, down 24% YoY. Net profit fell 35% to ₹15.55 lakhs. Company progressed on Schedule M compliance facility upgrades.

07 Feb 2026

co actions results

Ishita Drugs Board Meet Set for Feb 7 for Q3 Results

Ishita Drugs & Industries Ltd schedules board meeting on February 07, 2026 to approve Q3FY26 unaudited financial results. Trading window closed from January 1, 2026.

30 Jan 2026

co actions results

Ishita Drugs Promoter Acquires 254 Shares

Jagdish Agrawal, promoter of Ishita Drugs & Industries Ltd, acquired 254 shares worth ₹2,540 on December 29, 2025, increasing his stake to 4.41% from 4.40%.

31 Dec 2025

co actions results

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800